Alimera Sciences, Inc. ALIM
Set alert
5.54 +5.54 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 301.29M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 29.16
- Beta
- 1.25
- Short ratio
- 1.93
- Inst. own
- 86.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 24, 2024
- 50-d avg
- 5.56
- 200-d avg
- 4.23
- 1y target
- 5.67
Analyst view
Consensus: hold
Hold
Price target (mean) 5.67 +2.3% upside
Now 5.54
- Target (low)
- 5.50
- Target (mean)
- 5.67
- Target (high)
- 6.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.01 | -0.03 – 0.01 | -0.06 | +83.3% | 27.44M | +17.4% | 3 |
| Next quarter | 0.04 | 0.03 – 0.05 | -0.07 | +157.1% | 29.89M | +13.6% | 3 |
| Current year | -0.13 | -0.17 – -0.08 | -0.79 | +83.5% | 106.01M | +31.3% | 3 |
| Next year | 0.19 | 0.07 – 0.29 | -0.13 | +246.2% | 121.09M | +14.2% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 11, 2023 | Alliance Global Partners | Upgrade | Neutral | Buy |
| May 24, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 18, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 22, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 20, 2022 | Alliance Global Partners | Downgrade | Buy | Neutral |
| Jul 27, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 24, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 15, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 14, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 13, 2020 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 6, 2020 | B. Riley Securities | Maintained | — | Buy |
| Nov 17, 2019 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 30, 2019 | HC Wainwright & Co. | Maintained | — | Buy |
| May 27, 2019 | Craig-Hallum | Initiated | — | Buy |
| Jun 28, 2018 | B. Riley Securities | Initiated | — | Buy |
| Apr 26, 2017 | Rodman & Renshaw | Initiated | — | Buy |
| Sep 15, 2016 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| May 5, 2016 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Mar 3, 2016 | Cantor Fitzgerald | Maintained | — | Buy |
| Jan 18, 2016 | Cantor Fitzgerald | Maintained | — | Buy |
| Nov 16, 2014 | Summer Street | Initiated | — | Buy |
| Oct 27, 2013 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| Oct 6, 2013 | Northland Capital Markets | Upgrade | — | Outperform |
| Nov 29, 2012 | Oppenheimer | Maintained | — | Outperform |
